comparemela.com

Latest Breaking News On - Olujimi oyetomi - Page 8 : comparemela.com

FG cuts funding to fight rape by 49% in 2022 fiscal year

The Nigerian government has cut down its funding against rape, targeted at tracking and rehabilitation of survivors by 49% in the 2022 budget, from its

Perm Sec, Ministry of Women Affairs risks removal over N34m foreign trips

Women affairs ministry budgets N100m for three extra floors at headquarters

Women affairs ministry budgets N100m for three extra floors at headquarters
tribuneonlineng.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneonlineng.com Daily Mail and Mail on Sunday newspapers.

Women Affairs Ministry to house development partners for seamless engagements ― Perm Sec

Women Affairs Ministry to house development partners for seamless engagements ― Perm Sec
tribuneonlineng.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneonlineng.com Daily Mail and Mail on Sunday newspapers.

Covid lockdown worsens condition of sickle cell patients

We need your support to produce excellent journalism at all times. During the COVID-19 lockdown that lasted for over five months in Nigeria, a lot of Nigerians particularly the vulnerable were unable to access health centres. The ICIR’s NIYI OYEDEJI reports on how people living with Sickle Cell Disease (SCD) battled for survival during the lockdown. ON April 16, 2020, in the middle of the COVID-19 lockdown in Nigeria, pregnant Hauwah Abdulkareem, 34, a resident of Ilorin, who lives with Sickle Cell Disease (SCD) approached the University of Ilorin Teaching Hospital (UITH) while she was suffering from the vaso-occlusive crisis. The mother of two said she was astonished when she got to the UITH and was told to go back home, although she held  a referral form from a professional hematologist, she was told that her condition was not an emergency case

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.